Little Green Pharma Acquires Health House in Strategic Expansion, Shares Rise 4%

2 min read | February 05, 2025 03:22 PM AEDT | By Team Kalkine Media

Little Green Pharma Acquires Health House in Strategic Expansion, Shares Rise 4% — Image source: Shutterstock

Strategic Rationale and Deal Value

The acquisition aligns with LGP’s growth strategy, leveraging Health House’s established distribution network and annual revenue of $7.5 million (unaudited). Notably, the business has already achieved cashflow breakeven, making it a valuable asset for LGP’s portfolio.

LGP is acquiring Health House, along with its property, plant and equipment (PPE), inventory, and intellectual property, for just $375,000—significantly lower than the $10.9 million price tag listed by its former parent company, Melodiol Global Health (in liquidation), in September 2024.

The payment breakdown includes:

$75,000 deposit already paid.
$171,000 payable immediately.
Remaining $129,000 due in 40 days, once 31 January 2025 working capital is finalized.

LGP will also absorb Health House’s estimated $350,000 net liability position, excluding payables due to LGP.

Operational Integration & Market Impact

Following completion, LGP will seamlessly integrate Health House’s operations, systems, and personnel, ensuring minimal disruption to business continuity. Given Health House’s long-standing partnership with LGP, the acquisition is expected to create strong synergies, streamlining the company’s supply chain and bolstering its distribution capabilities.

The market responded positively to the news, with LGP shares rising 4% to 11.5 cents per share at the time of writing. Investors are likely encouraged by the low acquisition cost and the potential for revenue growth and operational efficiencies.

Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media Pty Ltd (Kalkine Media, we or us), ACN 629 651 672 and is available for personal and non-commercial use only. The principal purpose of the Content is to educate and inform. The Content does not contain or imply any recommendation or opinion intended to influence your financial decisions and must not be relied upon by you as such. Some of the Content on this website may be sponsored/non-sponsored, as applicable, but is NOT a solicitation or recommendation to buy, sell or hold the stocks of the company(s) or engage in any investment activity under discussion. Kalkine Media is neither licensed nor qualified to provide investment advice through this platform. Users should make their own enquiries about any investments and Kalkine Media strongly suggests the users to seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice), as necessary. Kalkine Media hereby disclaims any and all the liabilities to any user for any direct, indirect, implied, punitive, special, incidental or other consequential damages arising from any use of the Content on this website, which is provided without warranties. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media. Some of the images/music that may be used on this website are copyright to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures displayed/music used on this website unless stated otherwise. The images/music that may be used on this website are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source wherever it was indicated as or found to be necessary.